As of late Friday, about 65% of the roughly 175 readers that took our poll thought that KV's decision to hike the price of its new prenatal drug was a particularly bad idea.
The company recently won the exclusive rights to produce a shot that helps prevent premature births. However, the shot that once cost about $10 will now cost $1,500.
"All the upfront development of the drug was done by the National Institute of Health," Dr. Kevin Ault, associate professor of gynecology and obstetrics at Emory University School of Medicine, told ABC. "You and I paid for that with our tax dollars, it's not like this pharmaceutical company is trying to recoup its investments in research and development, as is usually the reason for the price of new drugs."The Food and Drug Administration's approval to grant KV exclusive rights to the product prevents the pharmacies that had been producing the shot from doing so anymore. It also prevents doctors from using anything but the KV formulation. With approximately 16% of votes, Gilbert Gottfried's tasteless tweets making light of the devastation in Japan was voted the second dumbest thing on Wall Street this week. Gottfried took to Twitter on Monday to make some inappropriate jokes about the tragedy in Japan. He was quickly fired as the voice of the Aflac (AFL) duck. Aflac quickly cut ties with the comedian following a string of similar comments.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV